Multispan, Inc.

Multispan, Inc., established in 2004, is positioned as a leader in biotechnology with its specialized assay screening technology. Brandishing the slogan "Better Medicine, One Assay at a Time", Multispan has carved a niche by focusing on GPCRs, kinases, and beyond, leveraging targets expressed in primary and recombinant stable cell lines.

The company prides itself on developing the industry’s largest and most characterized stable cell lines, enhancing assay development, HTS, and SAR lead optimization processes. These advancements have expedited time to IND and facilitated the discovery of better medicines across areas like cardiovascular, metabolic, CNS, inflammation, immunology, and oncology.

Thanks to its unwavering standards, Multispan has sealed long-term collaborations with top pharmaceutical and biotech firms globally. Despite their last known investment being $600.00K from Amkey Ventures in 2007, the company's strategic focus and integrity hold continued appeal for potential investors seeking substantial industry impact.